Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jareer Kassis

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Experimental Cell Research|August 11, 2004
DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signalingAsmaa Mamoune, Jareer Kassis, Sourabh Kharait, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signalingAlan Wells, Jose Carlos S Souto, James Solava, et al.
Cancer Research|September 23, 2003
Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinomaSufi Mary Thomas, Francesca M Coppelli, Alan Wells, et al.
Plos One|July 15, 2014
Induction of heme oxygenase I (HMOX1) by HPP-4382: a novel modulator of Bach1 activityOtis C Attucks, Kimberly J Jasmer, Mark Hannink, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Experimental Cell Research|August 11, 2004
DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signalingAsmaa Mamoune, Jareer Kassis, Sourabh Kharait, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signalingAlan Wells, Jose Carlos S Souto, James Solava, et al.
Cancer Research|September 23, 2003
Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinomaSufi Mary Thomas, Francesca M Coppelli, Alan Wells, et al.
Plos One|July 15, 2014
Induction of heme oxygenase I (HMOX1) by HPP-4382: a novel modulator of Bach1 activityOtis C Attucks, Kimberly J Jasmer, Mark Hannink, et al.
Pageof 2